Background The prevalence of duodenogastroesophageal reflux (DGER) and its effect on
symptoms and oesophageal lesions in gastroesophageal reflux disease (GERD) is unclear …

Rabeprazole is a proton pump inhibitor. Pharmacodynamic data show rabeprazole can
achieve optimal acid suppression since the first administration and can maintain this …

Background. Incomplete control of troublesome regurgitation and extraesophageal
manifestations of chronic gastroesophageal reflux disease (GERD) is a known limitation of …

Background. Questions remain about the therapeutic durability of transoral incisionless
fundoplication (TIF). In this study, clinical outcomes were evaluated at 5 years post-TIF 2.0 …

Gastroesophageal reflux disease (GERD) leads to the accumulation of bile-induced reactive
oxygen species and oxidative stress in esophageal tissues, causing inflammation and DNA …

BACKGROUND: This study was undertaken to validate previously reported safety and
symptomatic outcomes of transoral incisionless fundoplication (TIF), evaluate the relative …

Introduction The long-term management of gastroesophageal reflux in patients with Barrett's
esophagus (BE) is not well supported by an evidence-based consensus. We compare …

Background. To date, there are no long-term data on the use of transoral incisionless
fundoplication (TIF) for the treatment of chronic gastroesophageal reflux disease (GERD) …

Background Endoscopic endoluminal radiofrequency ablation is achieving increasing
acceptance as a mode of eliminating Barrett's metaplasia and, thus, reducing the risk of …

Purpose: This study aimed to assess the impact of transoral incisionless fundoplication (TIF)
on patients with chronic gastroesophageal reflux disease (GERD) at 12-month follow-up …